SPRY
ARS Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $410.72M
- Employees
- 154
- Latest publication
- 2026-09-29
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 33,658,000USD | 22,681,000USD | 28,087,000USD | 32,501,000USD | 15,717,000USD | 7,973,000USD | 86,581,000USD | 2,068,000USD |
| Research Development | 4,698,000USD | 4,336,000USD | 3,443,000USD | 2,751,000USD | 4,035,000USD | 2,952,000USD | 3,027,000USD | 4,423,000USD |
| Selling General Administrative | 77,579,000USD | 72,204,000USD | 59,955,000USD | 74,751,000USD | 54,312,000USD | 41,104,000USD | 36,183,000USD | 19,281,000USD |
| Total Operating Expenses | 95,123,000USD | 76,540,000USD | 66,350,000USD | 77,502,000USD | 58,347,000USD | 41,104,000USD | 35,492,000USD | 23,704,000USD |
| Operating Income | -61,465,000USD | -60,145,000USD | -41,465,000USD | -53,192,000USD | -47,614,000USD | -37,177,000USD | 47,197,000USD | -21,748,000USD |
| Total Other Income Expense Net | -874,000USD | -473,000USD | 61,000USD | 2,041,000USD | 2,731,000USD | 3,237,000USD | 3,025,000USD | 2,620,000USD |
| Net Income | -62,339,000USD | -60,618,000USD | -41,324,000USD | -51,151,000USD | -44,883,000USD | -33,940,000USD | 49,934,000USD | -19,128,000USD |
| Cost Of Revenue | — | 6,286,000USD | 3,202,000USD | 8,191,000USD | 4,984,000USD | 4,046,000USD | 3,892,000USD | 112,000USD |
| Gross Profit | — | 16,395,000USD | 24,885,000USD | 24,310,000USD | 10,733,000USD | 3,927,000USD | 82,689,000USD | 1,956,000USD |
| Interest Income | — | 1,968,000USD | — | — | — | 3,237,000USD | — | — |
| Interest Expense | — | 2,441,000USD | 2,599,000USD | — | — | 0USD | — | — |
| Net Interest Income | — | -473,000USD | — | — | — | 3,237,000USD | — | — |
| Income Before Tax | — | -60,618,000USD | -41,404,000USD | -51,151,000USD | -44,883,000USD | -33,940,000USD | 50,222,000USD | -19,128,000USD |
| Net Income From Continuing Ops | — | -60,618,000USD | -41,324,000USD | -51,151,000USD | -44,883,000USD | -33,940,000USD | 49,934,000USD | -19,128,000USD |
| Ebit | — | -60,145,000USD | -41,465,000USD | -51,151,000USD | -44,883,000USD | -37,177,000USD | 47,197,000USD | -21,748,000USD |
| Ebitda | — | -59,748,000USD | -41,048,000USD | -48,799,000USD | -44,604,000USD | -36,897,000USD | 47,226,000USD | -21,727,000USD |
| Depreciation And Amortization | — | 397,000USD | 417,000USD | 2,352,000USD | 279,000USD | 280,000USD | 29,000USD | 21,000USD |
| Reconciled Depreciation | — | -593,000USD | -586,000USD | -701,000USD | -1,188,000USD | -1,681,000USD | -1,515,000USD | -1,805,000USD |
| Unclassified Operating Expenses | — | — | 2,952,000USD | — | — | -2,952,000USD | -3,718,000USD | — |
| Income Tax Expense | — | — | -80,000USD | — | — | — | 288,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 84,278,000USD | 89,149,000USD | 30,000USD | 1,316,000USD | 5,506,000USD | 17,835,000USD | — | — |
| Cost Of Revenue | 20,423,000USD | 20,557,000USD | 73,000USD | 17,120,000USD | 213,000USD | 14,070,000USD | 1,546,000USD | 1,420,000USD |
| Gross Profit | 63,855,000USD | 68,592,000USD | 30,000USD | -15,804,000USD | 5,293,000USD | 3,765,000USD | -1,546,000USD | -1,420,000USD |
| Research Development | 13,181,000USD | 19,580,000USD | 20,266,000USD | 18,376,000USD | 20,273,000USD | 14,070,000USD | 21,505,000USD | 14,804,000USD |
| Selling General Administrative | 230,122,000USD | 71,675,000USD | 47,284,000USD | 18,456,000USD | 4,687,000USD | 4,234,000USD | — | — |
| Total Operating Expenses | 243,303,000USD | 71,675,000USD | 67,550,000USD | 19,712,000USD | 24,747,000USD | 4,234,000USD | 22,521,000USD | 16,900,000USD |
| Operating Income | -179,448,000USD | -3,083,000USD | -67,520,000USD | -35,516,000USD | -19,454,000USD | -469,000USD | -24,067,000USD | -18,320,000USD |
| Interest Income | 10,669,000USD | 11,369,000USD | — | — | — | — | — | — |
| Interest Expense | 2,599,000USD | 0USD | — | 834,000USD | 106,000USD | 29,000USD | — | — |
| Net Interest Income | 8,070,000USD | 11,369,000USD | — | — | — | — | — | — |
| Income Before Tax | -171,378,000USD | 8,286,000USD | -54,365,000USD | -34,682,000USD | -20,243,000USD | -1,065,000USD | -23,967,000USD | -17,579,000USD |
| Income Tax Expense | -80,000USD | 288,000USD | -94,895USD | -694,000USD | -230,558USD | -200,297USD | — | — |
| Tax Provision | -80,000USD | 288,000USD | 0USD | — | — | — | — | — |
| Net Income | -171,298,000USD | 7,998,000USD | -54,365,000USD | -34,682,000USD | -20,243,000USD | -1,065,000USD | -23,967,000USD | -17,579,000USD |
| Net Income From Continuing Ops | -171,298,000USD | 7,998,000USD | -61,626,000USD | -34,682,000USD | -20,243,000USD | -1,065,000USD | — | — |
| Ebit | -179,448,000USD | -3,083,000USD | -67,520,000USD | -35,516,000USD | -19,454,000USD | -469,000USD | -24,067,000USD | -18,320,000USD |
| Ebitda | -178,081,000USD | -3,004,000USD | -67,447,000USD | -35,197,000USD | -19,241,000USD | -463,000USD | -22,521,000USD | -16,900,000USD |
| Depreciation And Amortization | 1,367,000USD | 79,000USD | 73,000USD | 319,000USD | 213,000USD | 6,000USD | 1,546,000USD | 1,420,000USD |
| Reconciled Depreciation | -4,156,000USD | -7,175,000USD | 360,000USD | 319,000USD | 6,000USD | 6,000USD | — | — |
| Total Other Income Expense Net | 8,070,000USD | 11,369,000USD | 13,155,000USD | 834,000USD | -789,000USD | -596,000USD | 100,000USD | 741,000USD |
| Unclassified Operating Expenses | — | -19,580,000USD | — | -17,120,000USD | — | -14,070,000USD | 1,016,000USD | 2,096,000USD |
| Selling And Marketing Expenses | — | — | 73,000USD | — | — | — | — | — |
| Non Operating Income Net Other | — | — | — | 834,000USD | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -34,682,000USD | -20,243,000USD | -1,065,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 249,495,000USD | 287,571,000USD | 327,652,000USD | 372,803,000USD | 313,472,000USD | 327,318,000USD | 351,153,000USD | 217,601,000USD |
| Cash And Equivalents | 8,163,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 143,845,000USD | 200,969,000USD | 244,986,000USD | 288,209,000USD | 240,130,000USD | 275,727,000USD | 314,022,000USD | 204,624,000USD |
| Short Term Investments | 135,682,000USD | 176,648,000USD | 203,669,000USD | 228,652,000USD | 188,590,000USD | 235,863,000USD | 263,205,000USD | 164,967,000USD |
| Total Current Assets | 211,510,000USD | 245,236,000USD | 284,896,000USD | 338,863,000USD | 281,436,000USD | 303,860,000USD | 334,295,000USD | 208,789,000USD |
| Other Current Assets | 9,137,000USD | 6,788,000USD | 6,194,000USD | 6,421,000USD | 6,486,000USD | 10,589,000USD | 5,899,000USD | 2,211,000USD |
| Total Liabilities | 236,983,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 60,863,000USD | 49,612,000USD | 39,145,000USD | 50,877,000USD | 45,599,000USD | 27,622,000USD | 23,440,000USD | 16,623,000USD |
| Other Current Liabilities | 596,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 12,512,000USD | 61,308,000USD | 114,258,000USD | 147,655,000USD | 192,321,000USD | 228,974,000USD | 256,798,000USD | 200,978,000USD |
| Total Equity Including Noncontrolling Interest | 12,512,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 535,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 1,115,000USD | — | — | — | — | — | — | — |
| Net Receivables | 46,839,000USD | 28,662,000USD | 25,347,000USD | 36,451,000USD | 26,082,000USD | 10,274,000USD | 9,162,000USD | 1,239,000USD |
| Inventory | 30,734,000USD | 8,817,000USD | 8,369,000USD | 7,782,000USD | 8,738,000USD | 7,270,000USD | 5,212,000USD | 715,000USD |
| Property Plant Equipment Net | 2,085,000USD | 2,285,000USD | 2,465,000USD | 2,648,000USD | 2,639,000USD | 1,147,000USD | 1,066,000USD | 935,000USD |
| Intangible Assets | 13,900,000USD | 14,176,000USD | 14,452,000USD | 14,729,000USD | 13,160,000USD | 7,492,000USD | 7,685,000USD | 7,877,000USD |
| Accounts Payable | 5,198,000USD | 4,705,000USD | 5,725,000USD | 8,382,000USD | 15,559,000USD | 4,095,000USD | 9,870,000USD | 8,276,000USD |
| Common Stock | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Retained Earnings | -417,560,000USD | -355,221,000USD | -294,603,000USD | -253,279,000USD | -202,128,000USD | -157,245,000USD | -123,305,000USD | -173,239,000USD |
| Accumulated Other Comprehensive Income | -140,000USD | -96,000USD | 125,000USD | -7,000USD | -46,000USD | 72,000USD | 220,000USD | 339,000USD |
| Total Liab | — | 226,263,000USD | 213,394,000USD | 225,148,000USD | 121,151,000USD | 98,344,000USD | 94,355,000USD | 16,623,000USD |
| Other Current Liab | — | 44,315,000USD | 32,832,000USD | 41,912,000USD | 28,705,000USD | 22,914,000USD | 12,971,000USD | 8,245,000USD |
| Capital Stock | — | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 10,000USD |
| Cash | — | 24,321,000USD | 41,317,000USD | 59,557,000USD | 51,540,000USD | 39,864,000USD | 50,817,000USD | 39,657,000USD |
| Net Debt | — | 72,793,000USD | 55,645,000USD | -58,025,000USD | -49,879,000USD | -39,791,000USD | -50,775,000USD | -39,555,000USD |
| Short Term Debt | — | 592,000USD | 588,000USD | 583,000USD | 589,000USD | 73,000USD | 42,000USD | 102,000USD |
| Short Long Term Debt Total | — | 97,114,000USD | 96,962,000USD | 1,532,000USD | 1,661,000USD | 73,000USD | 42,000USD | 102,000USD |
| Long Term Debt | — | 96,522,000USD | 96,374,000USD | 96,229,000USD | — | — | — | — |
| Common Stock Shares Outstanding | — | 99,296,408shares | 98,566,481shares | 98,807,600shares | 98,361,771shares | 98,060,636shares | 97,954,172shares | 97,032,331shares |
| Non Current Assets Total | — | 42,335,000USD | 42,756,000USD | 33,940,000USD | 32,036,000USD | 23,458,000USD | 16,858,000USD | 8,812,000USD |
| Non Current Liabilities Total | — | 176,651,000USD | 174,249,000USD | 174,271,000USD | 75,552,000USD | 70,722,000USD | 70,915,000USD | 0USD |
| Non Current Liabilities Other | — | 74,673,000USD | 72,140,000USD | 72,044,000USD | 71,959,000USD | 69,383,000USD | 69,383,000USD | — |
| Non Currrent Assets Other | — | 25,874,000USD | 25,839,000USD | 16,563,000USD | 16,237,000USD | 14,819,000USD | 8,107,000USD | 377,000USD |
| Net Working Capital | — | 195,624,000USD | 245,751,000USD | 287,986,000USD | 235,837,000USD | 276,238,000USD | 310,855,000USD | 192,166,000USD |
| Unclassified Non Current Liabilities | — | 5,456,000USD | 5,735,000USD | 5,998,000USD | 3,593,000USD | 1,339,000USD | 1,532,000USD | — |
| Unclassified Equity | — | 416,605,000USD | 408,716,000USD | 400,921,000USD | 394,475,000USD | 386,127,000USD | 379,863,000USD | 373,858,000USD |
| Property Plant Equipment Gross | — | — | — | 2,648,000USD | 2,639,000USD | 1,147,000USD | 1,266,000USD | 1,106,000USD |
| Current Deferred Revenue | — | — | — | — | 746,000USD | 540,000USD | 557,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 327,652,000USD | 351,153,000USD | 233,188,000USD | 281,435,000USD | 61,446,000USD | 26,407,000USD | 15,647,000USD | 27,547,000USD |
| Intangible Assets | 14,452,000USD | 7,685,000USD | 617,000USD | — | — | — | — | — |
| Other Current Assets | 6,194,000USD | 5,899,000USD | 2,408,000USD | 3,319,000USD | 666,000USD | 1,477,000USD | 552,000USD | 618,000USD |
| Total Liab | 213,394,000USD | 94,355,000USD | 2,428,000USD | 8,549,000USD | 92,715,000USD | 40,459,000USD | 21,250,000USD | 9,350,000USD |
| Total Stockholder Equity | 114,258,000USD | 256,798,000USD | 230,760,000USD | 272,886,000USD | -31,269,000USD | -14,052,000USD | -5,603,000USD | 18,197,000USD |
| Other Current Liab | 32,832,000USD | 12,971,000USD | 1,391,000USD | 3,555,000USD | 1,321,000USD | 915,000USD | 2,112,000USD | 841,000USD |
| Common Stock | 10,000USD | 10,000USD | 10,000USD | 9,000USD | 3,000USD | 223,000USD | — | — |
| Capital Stock | 10,000USD | 10,000USD | 10,000USD | 9,000USD | 257,000USD | 223,000USD | — | — |
| Retained Earnings | -294,603,000USD | -123,305,000USD | -131,303,000USD | -76,938,000USD | -42,256,000USD | -22,013,000USD | -63,787,000USD | -39,820,000USD |
| Cash | 41,317,000USD | 50,817,000USD | 70,971,000USD | 210,518,000USD | 60,063,000USD | 24,521,000USD | 9,976,000USD | 20,160,000USD |
| Cash And Short Term Investments | 244,986,000USD | 314,022,000USD | 228,360,000USD | 274,381,000USD | 60,063,000USD | 24,521,000USD | 9,976,000USD | 20,160,000USD |
| Total Current Assets | 284,896,000USD | 334,295,000USD | 231,563,000USD | 277,700,000USD | 60,730,000USD | 26,382,000USD | 10,528,000USD | 20,778,000USD |
| Total Current Liabilities | 39,145,000USD | 23,440,000USD | 2,391,000USD | 5,444,000USD | 8,187,000USD | 8,210,000USD | 17,926,000USD | 5,144,000USD |
| Net Debt | 55,645,000USD | -50,775,000USD | -70,697,000USD | -210,037,000USD | -51,030,000USD | -14,503,000USD | 5,644,000USD | -12,426,000USD |
| Short Term Debt | 588,000USD | 42,000USD | 237,000USD | 230,000USD | 3,623,000USD | 2,558,000USD | 12,296,000USD | 3,528,000USD |
| Short Long Term Debt Total | 96,962,000USD | 42,000USD | 274,000USD | 481,000USD | 9,033,000USD | 10,018,000USD | 15,620,000USD | 7,734,000USD |
| Long Term Debt | 96,374,000USD | — | — | — | 4,930,000USD | 7,460,000USD | — | — |
| Short Term Investments | 203,669,000USD | 263,205,000USD | 157,389,000USD | 63,863,000USD | 0USD | — | — | — |
| Net Receivables | 25,347,000USD | 9,162,000USD | 795,000USD | 1,009,000USD | 1,000USD | 384,000USD | — | — |
| Inventory | 8,369,000USD | 5,212,000USD | 0USD | -1,009,000USD | -6,781,000USD | -2,610,000USD | — | — |
| Accounts Payable | 5,725,000USD | 9,870,000USD | 759,000USD | 1,659,000USD | 1,786,000USD | 1,219,000USD | 3,518,000USD | 775,000USD |
| Property Plant Equipment Net | 2,465,000USD | 1,066,000USD | 824,000USD | 774,000USD | 693,000USD | 23,000USD | 4,569,000USD | 6,019,000USD |
| Accumulated Other Comprehensive Income | 125,000USD | 220,000USD | 49,000USD | 406,999USD | -326,000USD | -21,233,000USD | — | — |
| Common Stock Shares Outstanding | 98,566,481shares | 102,390,828shares | 95,215,322shares | 39,956,043shares | 28,872,242shares | 34,701,274shares | 33,066,709shares | 33,066,709shares |
| Non Current Assets Total | 42,756,000USD | 16,858,000USD | 1,625,000USD | 3,735,000USD | 716,000USD | 25,000USD | 5,119,000USD | 6,769,000USD |
| Non Current Liabilities Total | 174,249,000USD | 70,915,000USD | 36,999USD | 3,105,000USD | 84,528,000USD | 32,249,000USD | 3,324,000USD | 4,206,000USD |
| Non Current Liabilities Other | 72,140,000USD | 69,383,000USD | — | 3,105,000USD | — | 27,000USD | — | — |
| Non Currrent Assets Other | 25,839,000USD | 8,107,000USD | 801,000USD | 2,961,000USD | 23,000USD | 2,000USD | — | — |
| Net Working Capital | 245,751,000USD | 310,855,000USD | 229,335,000USD | 272,256,000USD | 52,543,000USD | 18,172,000USD | — | — |
| Unclassified Non Current Liabilities | 5,735,000USD | 1,532,000USD | — | -2,854,000USD | 76,519,000USD | 21,206,000USD | 3,324,000USD | 4,206,000USD |
| Unclassified Equity | 408,716,000USD | 379,863,000USD | 361,994,000USD | 349,399,001USD | 11,053,000USD | 28,748,000USD | 58,184,000USD | 58,017,000USD |
| Current Deferred Revenue | — | 557,000USD | 4,000USD | 283,000USD | 1,457,000USD | 3,518,000USD | — | — |
| Property Plant Equipment Gross | — | 1,266,000USD | 945,000USD | 822,000USD | 707,000USD | 31,000USD | — | — |
| Other Liab | — | — | — | 2,854,000USD | 3,079,000USD | 3,556,000USD | — | — |
| Other Assets | — | — | — | 2,961,000USD | 23,000USD | 2,000USD | — | — |
| Net Tangible Assets | — | — | — | 272,886,000USD | -31,269,000USD | -14,052,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | -2,961,000USD | — | — | — | — |
| Short Long Term Debt | — | — | — | — | 3,479,000USD | 2,558,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | -3,479,000USD | -2,558,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 813,000USD |
| Stock Based Compensation | 19,818,000USD |
| Other Non Cash Items | -2,331,000USD |
| Change To Account Receivables | -21,469,000USD |
| Change To Inventory | -281,000USD |
| Change To Liabilities | 20,839,000USD |
| Change In Working Capital | -4,149,000USD |
| Operating Cash Flow | -105,873,000USD |
| Capital Expenditures | 0USD |
| Unclassified Investing Cash Flow | 69,363,000USD |
| Investing Cash Flow | 69,363,000USD |
| Common Stock Issuance | 848,000USD |
| Unclassified Financing Cash Flow | 2,508,000USD |
| Financing Cash Flow | 3,356,000USD |
| Change In Cash | -33,154,000USD |
| End Cash Flow | 8,163,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -60,618,000USD | -41,324,000USD | -51,151,000USD | -44,883,000USD | -33,940,000USD | 49,934,000USD | -19,128,000USD | -12,516,000USD |
| Depreciation | 397,000USD | -1,544,000USD | 2,352,000USD | 279,000USD | -1,681,000USD | -1,515,000USD | 21,000USD | 18,000USD |
| Stock Based Compensation | 7,423,000USD | 5,737,000USD | 5,689,000USD | 5,371,000USD | 5,298,000USD | 4,263,000USD | 3,591,000USD | 3,365,000USD |
| Other Non Cash Items | -745,000USD | 1,109,000USD | -2,867,000USD | 693,000USD | -4,000USD | 2,590,000USD | 1,765,000USD | -1,904,000USD |
| Change To Account Receivables | -839,000USD | 11,177,000USD | -14,007,000USD | -13,247,000USD | -1,128,000USD | -7,402,000USD | -773,000USD | 0USD |
| Change To Inventory | -294,000USD | -9,717,000USD | 963,000USD | -4,783,000USD | -8,449,000USD | -5,762,000USD | -183,000USD | 0USD |
| Change In Working Capital | 8,597,000USD | -7,463,000USD | -1,070,000USD | -1,052,000USD | -10,419,000USD | -10,678,000USD | 2,875,000USD | 3,758,000USD |
| Total Cash From Operating Activities | -44,946,000USD | -43,485,000USD | -47,047,000USD | -39,592,000USD | -40,742,000USD | 42,004,000USD | -14,467,000USD | -7,279,000USD |
| Capital Expenditures | 0USD | 0USD | -197,000USD | -51,000USD | -91,000USD | -302,000USD | -140,000USD | -38,000USD |
| Free Cash Flow | -44,946,000USD | -43,485,000USD | -47,244,000USD | -39,643,000USD | -40,833,000USD | 41,702,000USD | -14,607,000USD | -7,317,000USD |
| Investments | 27,791,000USD | 26,114,000USD | -44,981,000USD | 48,571,000USD | 29,064,000USD | -101,760,000USD | 16,818,000USD | -12,646,000USD |
| Total Cashflows From Investing Activities | 27,791,000USD | 24,114,000USD | -44,981,000USD | 48,571,000USD | 29,064,000USD | -101,760,000USD | 16,818,000USD | -12,646,000USD |
| Total Cash From Financing Activities | 159,000USD | 1,131,000USD | 100,045,000USD | 2,697,000USD | 725,000USD | 70,916,000USD | 680,000USD | 545,000USD |
| Change In Cash | -16,996,000USD | -18,240,000USD | 8,017,000USD | 11,676,000USD | -10,953,000USD | 11,160,000USD | 3,031,000USD | -19,380,000USD |
| Begin Period Cash Flow | 41,317,000USD | 59,557,000USD | 51,540,000USD | 39,864,000USD | 50,817,000USD | 39,657,000USD | 36,626,000USD | 56,006,000USD |
| End Period Cash Flow | 24,321,000USD | 41,317,000USD | 59,557,000USD | 51,540,000USD | 39,864,000USD | 50,817,000USD | 39,657,000USD | 36,626,000USD |
| Other Cashflows From Financing Activities | 97,000USD | 83,000USD | 2,577,000USD | 2,697,000USD | 725,000USD | 69,383,000USD | 680,000USD | 545,000USD |
| Net Borrowings | — | -732,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | -2,000,000USD | -5,860,000USD | — | — | -5,000,000USD | -2,500,000USD | — |
| Unclassified Financing Cash Flow | — | 1,780,000USD | 97,468,000USD | — | — | 1,533,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | 6,057,000USD | — | — | 5,302,000USD | 2,640,000USD | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -2,590,000USD | -3,591,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -171,298,000USD | 7,998,000USD | -54,365,000USD | -34,682,000USD | -20,243,000USD | -1,065,000USD | -23,967,000USD | -17,579,000USD |
| Depreciation | 1,367,000USD | -7,175,000USD | 73,000USD | 319,000USD | 213,000USD | 6,000USD | 1,546,000USD | 1,420,000USD |
| Stock Based Compensation | 22,095,000USD | 14,534,000USD | 9,235,000USD | 5,843,000USD | 2,829,000USD | 3,544,000USD | — | — |
| Other Non Cash Items | -3,026,000USD | -1,809,000USD | -6,878,000USD | 1,196,000USD | -4,000USD | 121,000USD | 223,000USD | 2,044,000USD |
| Change To Account Receivables | -17,205,000USD | -8,175,000USD | 0USD | — | — | — | — | — |
| Change To Inventory | -21,986,000USD | -5,945,000USD | 0USD | — | — | — | — | — |
| Change In Working Capital | -20,004,000USD | -1,809,000USD | -7,331,000USD | -12,754,000USD | -356,000USD | 6,464,000USD | 3,300,000USD | -433,000USD |
| Total Cash From Operating Activities | -170,866,000USD | 13,548,000USD | -59,266,000USD | -40,078,000USD | -17,561,000USD | 9,071,000USD | -18,898,000USD | -16,875,000USD |
| Capital Expenditures | -339,000USD | -563,000USD | -175,000USD | -199,000USD | -55,000USD | -917,000USD | -96,000USD | -449,000USD |
| Free Cash Flow | -171,205,000USD | 12,985,000USD | -59,441,000USD | -40,277,000USD | -17,616,000USD | 8,154,000USD | -18,994,000USD | -17,324,000USD |
| Investments | 64,967,000USD | -106,101,000USD | -113,345,000USD | 63,473,000USD | -55,000USD | 0USD | — | — |
| Total Cashflows From Investing Activities | 56,768,000USD | -106,101,000USD | -87,180,000USD | -199,000USD | -55,000USD | -917,000USD | -96,000USD | -449,000USD |
| Net Borrowings | 96,257,000USD | 0USD | 0USD | -8,681,000USD | -1,817,000USD | 5,000,000USD | — | — |
| Total Cash From Financing Activities | 104,598,000USD | 72,399,000USD | 6,899,000USD | 190,732,000USD | 53,158,000USD | 5,099,000USD | 8,610,000USD | 19,399,000USD |
| Change In Cash | -9,500,000USD | -20,154,000USD | -139,547,000USD | 150,455,000USD | 35,542,000USD | 14,170,000USD | -10,184,000USD | 2,075,000USD |
| Begin Period Cash Flow | 50,817,000USD | 70,971,000USD | 210,518,000USD | 60,063,000USD | 24,521,000USD | 10,351,000USD | 20,160,000USD | 18,085,000USD |
| End Period Cash Flow | 41,317,000USD | 50,817,000USD | 70,971,000USD | 210,518,000USD | 60,063,000USD | 24,521,000USD | 9,976,000USD | 20,160,000USD |
| Other Cashflows From Investing Activities | -7,860,000USD | -7,500,000USD | — | — | 65,106,000USD | — | — | — |
| Other Cashflows From Financing Activities | 2,660,000USD | 72,399,000USD | 6,899,000USD | 198,843,000USD | 54,975,000USD | -409,107,000USD | -96,000USD | — |
| Unclassified Financing Cash Flow | 5,681,000USD | — | — | — | -54,806,000USD | 409,206,000USD | 8,706,000USD | — |
| Unclassified Operating Cash Flow | — | 1,809,000USD | — | — | — | — | — | -2,327,000USD |
| Unclassified Investing Cash Flow | — | 8,063,000USD | 26,340,000USD | -63,473,000USD | -65,051,000USD | — | — | — |
| Change To Liabilities | — | — | — | -10,285,000USD | -1,533,000USD | 8,149,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | 570,000USD | — | — | — | — |
| Issuance Of Capital Stock | — | — | — | 0USD | 54,806,000USD | 0USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 150,455,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Geography | DK | 2,777,000 | USD | 0001193125-26-225142 |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 2,452,000 | USD | 0001193125-26-225142 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 17,452,000 | USD | 0001193125-26-225142 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 17,452,000 | USD | 0001193125-26-225142 |
| Q1 2026Quarterly · 2026-03-31 | Product | Revenue Under Collaboration Agreements | 2,489,000 | USD | 0001193125-26-225142 |
| Q1 2026Quarterly · 2026-03-31 | Product | Revenue Under Supply Agreements | 2,740,000 | USD | 0001193125-26-225142 |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 20,329,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Revenue Under Collaboration Agreements | 6,857,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Revenue Under Supply Agreements | 901,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 12,086,000 | USD | 0001193125-26-097478 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 72,192,000 | USD | 0001193125-26-097478 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 72,192,000 | USD | 0001193125-26-097478 |
| FY 2025Yearly · 2025-12-31 | Product | Revenue Under Collaboration Agreements | 9,716,000 | USD | 0001193125-26-097478 |
| FY 2025Yearly · 2025-12-31 | Product | Revenue Under Supply Agreements | 2,370,000 | USD | 0001193125-26-097478 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 31,300,000 | USD | 0001193125-25-273111 |
| Q3 2025Quarterly · 2025-09-30 | Product | Revenue Under Collaboration Agreements | 55,000 | USD | 0001193125-25-273111 |
| Q3 2025Quarterly · 2025-09-30 | Product | Revenue Under Supply Agreements | 1,146,000 | USD | 0001193125-25-273111 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 12,800,000 | USD | 0000950170-25-107618 |
| Q2 2025Quarterly · 2025-06-30 | Product | Revenue Under Collaboration Agreements | 2,594,000 | USD | 0000950170-25-107618 |
| Q2 2025Quarterly · 2025-06-30 | Product | Revenue Under Supply Agreements | 323,000 | USD | 0000950170-25-107618 |
| Q1 2025Quarterly · 2025-03-31 | Geography | DK | 210,000 | USD | 0001193125-26-225142 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 0 | USD | 0001193125-26-225142 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 7,763,000 | USD | 0001193125-26-225142 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 7,763,000 | USD | 0001193125-26-225142 |
| Q1 2025Quarterly · 2025-03-31 | Product | Revenue Under Collaboration Agreements | 210,000 | USD | 0001193125-26-225142 |
| Q1 2025Quarterly · 2025-03-31 | Product | Revenue Under Supply Agreements | 0 | USD | 0001193125-26-225142 |
| FY 2024Yearly · 2024-12-31 | Geography | International | 81,894,000 | USD | 0001193125-26-097478 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 7,255,000 | USD | 0001193125-26-097478 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 7,255,000 | USD | 0001193125-26-097478 |
| FY 2024Yearly · 2024-12-31 | Product | Revenue Under Collaboration Agreements | 81,529,000 | USD | 0001193125-26-097478 |
| FY 2024Yearly · 2024-12-31 | Product | Revenue Under Supply Agreements | 365,000 | USD | 0001193125-26-097478 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 568,000 | USD | 0001193125-25-273111 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenue Under Collaboration Agreements | 1,500,000 | USD | 0001193125-25-273111 |
| Q3 2024Quarterly · 2024-09-30 | Product | Revenue Under Supply Agreements | 0 | USD | 0001193125-25-273111 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 0 | USD | 0000950170-25-107618 |
| Q2 2024Quarterly · 2024-06-30 | Product | Revenue Under Collaboration Agreements | 500,000 | USD | 0000950170-25-107618 |
| Q2 2024Quarterly · 2024-06-30 | Product | Revenue Under Supply Agreements | 0 | USD | 0000950170-25-107618 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 0 | USD | 0000950170-25-042320 |
| FY 2023Yearly · 2023-12-31 | Product | Revenue Under Collaboration Agreements | 30,000 | USD | 0000950170-25-042320 |
| FY 2023Yearly · 2023-12-31 | Product | Revenue Under Supply Agreements | 0 | USD | 0000950170-25-042320 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.